Recherche en laboratoire

Study on the development of a prototype vaccine against SARS-CoV-2 that can be administered intranasally in a single dose.

CIBERES UCI COVID is a fundamental study that will improve care of critical patients infected by COVID-19.

This study aims to genetically analyse SARS-CoV-2 in the Armenian population using whole-genome nanopore sequencing.

This study aims to characterise the pharmacological profile of raloxifene against bradykinin receptors to treat inflammatory processes due to COVID-19.

Is the MMR vaccine involved in the immune response to SARS-CoV-2? This study aims to answer that question by investigating the effect of the MMR vaccine on COVID-19.

Are you immunosuppressed? Engage this study and help underestand the kinetics of adaptive immunization against COVID-19.

How do host’s genetics influence the susceptibility and severity of the infection? Find out more in GEN-COVID, a COVID-19 study about genetics.

This study aims to better understand the functioning of the immune response to SARS CoV-2 in order to propose new treatments based on the body’s cellular response to COVID-19.